NEWS & UPDATES
SAFETY ALERTS FOR MEDICINES AND ALLIED SUBSTANCES.
While medicines and vaccines are studied in well controlled clinical trials and reviewed by regulatory authorities with the aim of ensuring benefits outweigh risks, some adverse effects are observed only once the product is authorized by regulators and used by a larger population in real world conditions. It is therefore essential that medical products continue to be monitored for their effectiveness and safety post release.
MEDICAL PRODUCT ALERT : RECALL OF BENYLIN PAEDIATRIC COUGH SYRUP 100ML BATCH NO. 329304 MANUFACTURED BY JOHNSON & JOHNSON (PTY), SOUTH AFRICA
ZAMRA Alert NO. 1_12042024-3Download
Medical Product Advisory : FALSIFIED OZEMPIC® IN CIRCULATION
Advisory_Falsified Ozempic_07112023Download
Medical Product Alert : SUPERLIFE STC30 – UNAPPROVED MEDICAL CLAIMS
Media Alert_STC30_08112023Download
PARTNERS
